Baker Biotech Capital III (GP), LLC

10% owner at Aceragen, Inc. · on record since Mar 29, 2006
10% owner at Ardea Biosciences, Inc./DE · on record since Feb 28, 2006
10% owner at Ocera Therapeutics, Inc. · on record since Mar 14, 2012
10% owner at VIROPHARMA INC · on record since Mar 1, 2006
Director at Seagen Inc. · on record since Jun 29, 2006
10% owner at Seagen Inc. · on record since Jun 29, 2006
10% owner at TAPESTRY PHARMACEUTICALS, INC · on record since Apr 28, 2006
Director at SYNAGEVA BIOPHARMA CORP · on record since Apr 28, 2006
10% owner at SYNAGEVA BIOPHARMA CORP · on record since Apr 28, 2006
Director at NEUROGEN CORP · on record since Apr 28, 2006
10% owner at NEUROGEN CORP · on record since Apr 28, 2006
Director at GENOMIC HEALTH INC · on record since Sep 11, 2006
10% owner at ALLOS THERAPEUTICS INC · on record since Nov 30, 2006
10% owner at GENOMIC HEALTH INC · on record since Feb 21, 2007
10% owner at AUXILIUM PHARMACEUTICALS INC · on record since Mar 11, 2010
10% owner at BIOCRYST PHARMACEUTICALS INC · on record since Aug 8, 2007
10% owner at Synvista Therapeutics, Inc. · on record since Aug 3, 2007
Director at INCYTE CORP · on record since Aug 3, 2007
10% owner at · on record since Dec 19, 2007
10% owner at · on record since Oct 28, 2009
10% owner at · on record since Apr 28, 2010
Director at · on record since Apr 8, 2010
10% owner at · on record since Jul 29, 2010
10% owner at · on record since Aug 24, 2011
10% owner at · on record since Mar 8, 2012

Insider trading activity of Baker Biotech Capital III (GP), LLC

Transactions on record: 300; since Feb 14, 2005

Open-market buys: 205; $284.1M

Open-market sells: 39; $26M

Companies traded: 13; last filing Mar 5, 2012

Figures computed from official regulatory filings — .

Companies where Baker Biotech Capital III (GP), LLC has traded

66 tx · $57.4M · Mar 5, 2012
19 tx · $10.8M · Jan 23, 2012
39 tx · $1.1B · Dec 7, 2011
63 tx · $89M · Aug 25, 2011
26 tx · $4.6M · Aug 12, 2011
13 tx · $671.5K · Jul 5, 2011
13 tx · $24M · Jul 5, 2011
4 tx · Jul 5, 2011
14 tx · $34.2M · Mar 31, 2011
6 tx · $2.2M · Jun 1, 2009
13 tx · $18.6M · Feb 6, 2009
1 tx · Oct 17, 2008
23 tx · $5.4M · Sep 30, 2008

Track record of Baker Biotech Capital III (GP), LLC

Statistical track record

Free account

Open-market buys: 231

Last buy: Mar 5, 2012

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of Baker Biotech Capital III (GP), LLC

Co-insiders of Baker Biotech Capital III (GP), LLC

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
GENOMIC HEALTH INCListing unverified	Mar 5, 2012	Buy	69,783	30.07 USD	$2.1M	conv 33Cluster	SEC
GENOMIC HEALTH INCListing unverified	Mar 5, 2012	Buy	15,288	29.47 USD	$450.5K	conv 25Cluster	SEC
GENOMIC HEALTH INCListing unverified	Mar 5, 2012	Buy	91,459	29.52 USD	$2.7M	conv 38Cluster	SEC
GENOMIC HEALTH INCListing unverified	Mar 5, 2012	Buy	85,231	29.96 USD	$2.6M	conv 37Cluster	SEC
GENOMIC HEALTH INCListing unverified	Feb 16, 2012	Buy	349	28.96 USD	$10.1K	conv 24Cluster	SEC
GENOMIC HEALTH INCListing unverified	Feb 16, 2012	Buy	55,804	28.44 USD	$1.6M	conv 25Cluster	SEC
GENOMIC HEALTH INCListing unverified	Feb 16, 2012	Buy	32,125	28.88 USD	$927.8K	conv 25Cluster	SEC
GENOMIC HEALTH INCListing unverified	Feb 16, 2012	Buy	91,543	29.85 USD	$2.7M	conv 28Cluster	SEC
GENOMIC HEALTH INCListing unverified	Feb 16, 2012	Buy	93,088	29.61 USD	$2.8M	conv 28Cluster	SEC
PHARMACYCLICS INCListing unverified	Jan 23, 2012	Buy	178,921	16.41 USD	$2.9M	conv 26Cluster	SEC
PHARMACYCLICS INCListing unverified	Jan 23, 2012	Buy	45,574	16.84 USD	$767.5K	conv 25Cluster	SEC
PHARMACYCLICS INCListing unverified	Jan 23, 2012	Buy	22,081	16.07 USD	$354.8K	conv 26Cluster	SEC
PHARMACYCLICS INCListing unverified	Jan 23, 2012	Other	16,200	15.00 USD	$243K	Unusual size	SEC
PHARMACYCLICS INCListing unverified	Jan 23, 2012	Buy	43,644	16.90 USD	$737.6K	conv 25Cluster	SEC
PHARMACYCLICS INCListing unverified	Jan 23, 2012	BuyD (derivative)	162	1.25 USD	$202.5	Cluster	SEC
PHARMACYCLICS INCListing unverified	Jan 23, 2012	Buy	69,245	16.43 USD	$1.1M	conv 25Cluster	SEC
PHARMACYCLICS INCListing unverified	Jan 23, 2012	Buy	10,327	16.07 USD	$166K	conv 26Cluster	SEC
PHARMACYCLICS INCListing unverified	Jan 23, 2012	OtherD (derivative)	-162	1.25 USD	$202.5		SEC
PHARMACYCLICS INCListing unverified	Jan 23, 2012	BuyD (derivative)	87	1.50 USD	$130.5	Cluster	SEC
PHARMACYCLICS INCListing unverified	Jan 23, 2012	Buy	2,449	15.81 USD	$38.7K	conv 26Cluster	SEC
PHARMACYCLICS INCListing unverified	Jan 23, 2012	Buy	72,997	16.88 USD	$1.2M	conv 25Cluster	SEC
PHARMACYCLICS INCListing unverified	Jan 23, 2012	Other	8,700	15.00 USD	$130.5K	Unusual size	SEC
PHARMACYCLICS INCListing unverified	Jan 23, 2012	OtherD (derivative)	-87	1.50 USD	$130.5		SEC
INCYTE CORPListing on record	Dec 7, 2011	Buy	192,316	13.52 USD	$2.6M	conv 30Cluster	SEC
INCYTE CORPListing on record	Dec 7, 2011	Buy	1,023,128	13.89 USD	$14.2M	conv 54ClusterUnusual size	SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
GENOMIC HEALTH INCListing unverified	Mar 5, 2012	Buy	69,783	30.07 USD	$2.1M	conv 33Cluster	SEC
GENOMIC HEALTH INCListing unverified	Mar 5, 2012	Buy	15,288	29.47 USD	$450.5K	conv 25Cluster	SEC
GENOMIC HEALTH INCListing unverified	Mar 5, 2012	Buy	91,459	29.52 USD	$2.7M	conv 38Cluster	SEC
GENOMIC HEALTH INCListing unverified	Mar 5, 2012	Buy	85,231	29.96 USD	$2.6M	conv 37Cluster	SEC
GENOMIC HEALTH INCListing unverified	Feb 16, 2012	Buy	349	28.96 USD	$10.1K	conv 24Cluster	SEC
GENOMIC HEALTH INCListing unverified	Feb 16, 2012	Buy	55,804	28.44 USD	$1.6M	conv 25Cluster	SEC
GENOMIC HEALTH INCListing unverified	Feb 16, 2012	Buy	32,125	28.88 USD	$927.8K	conv 25Cluster	SEC
GENOMIC HEALTH INCListing unverified	Feb 16, 2012	Buy	91,543	29.85 USD	$2.7M	conv 28Cluster	SEC
GENOMIC HEALTH INCListing unverified	Feb 16, 2012	Buy	93,088	29.61 USD	$2.8M	conv 28Cluster	SEC
PHARMACYCLICS INCListing unverified	Jan 23, 2012	Buy	178,921	16.41 USD	$2.9M	conv 26Cluster	SEC
PHARMACYCLICS INCListing unverified	Jan 23, 2012	Buy	45,574	16.84 USD	$767.5K	conv 25Cluster	SEC
PHARMACYCLICS INCListing unverified	Jan 23, 2012	Buy	22,081	16.07 USD	$354.8K	conv 26Cluster	SEC
PHARMACYCLICS INCListing unverified	Jan 23, 2012	Other	16,200	15.00 USD	$243K	Unusual size	SEC
PHARMACYCLICS INCListing unverified	Jan 23, 2012	Buy	43,644	16.90 USD	$737.6K	conv 25Cluster	SEC
PHARMACYCLICS INCListing unverified	Jan 23, 2012	BuyD (derivative)	162	1.25 USD	$202.5	Cluster	SEC
PHARMACYCLICS INCListing unverified	Jan 23, 2012	Buy	69,245	16.43 USD	$1.1M	conv 25Cluster	SEC
PHARMACYCLICS INCListing unverified	Jan 23, 2012	Buy	10,327	16.07 USD	$166K	conv 26Cluster	SEC
PHARMACYCLICS INCListing unverified	Jan 23, 2012	OtherD (derivative)	-162	1.25 USD	$202.5		SEC
PHARMACYCLICS INCListing unverified	Jan 23, 2012	BuyD (derivative)	87	1.50 USD	$130.5	Cluster	SEC
PHARMACYCLICS INCListing unverified	Jan 23, 2012	Buy	2,449	15.81 USD	$38.7K	conv 26Cluster	SEC
PHARMACYCLICS INCListing unverified	Jan 23, 2012	Buy	72,997	16.88 USD	$1.2M	conv 25Cluster	SEC
PHARMACYCLICS INCListing unverified	Jan 23, 2012	Other	8,700	15.00 USD	$130.5K	Unusual size	SEC
PHARMACYCLICS INCListing unverified	Jan 23, 2012	OtherD (derivative)	-87	1.50 USD	$130.5		SEC
INCYTE CORPListing on record	Dec 7, 2011	Buy	192,316	13.52 USD	$2.6M	conv 30Cluster	SEC
INCYTE CORPListing on record	Dec 7, 2011	Buy	1,023,128	13.89 USD	$14.2M	conv 54ClusterUnusual size	SEC